DAB2 and hepatocellular carcinoma: In clinical practice, to measure the transcript level of only ADAM15, CDC42, DAB2, ITGB1BP1, ITGB5, KIF14, LIMS2, and SELP might be a cost-effective application and enabled to offer accurate prognostic prediction of HCC.